Litigation Details for TriDiNetworks Ltd. v. Signify North America Corporation (D. Del. 2019)
✉ Email this page to a colleague
TriDiNetworks Ltd. v. Signify North America Corporation (D. Del. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-06-07 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | Plaintiff | Referred To | Christopher J. Burke |
Patents | 10,004,812; 10,029,015; 10,072,053; 10,114,012; 10,271,547; 10,357,032; 10,364,437; 10,548,925; 10,550,357; 10,550,437; 6,004,549; 6,010,726; 6,028,057; 6,803,033; 7,037,692; 7,271,210; 7,544,364; 7,803,636; 8,008,006; 8,026,276; 8,030,539; 8,030,545; 8,044,014; 8,062,044; 8,541,044; 8,541,210; 8,541,636; 8,692,006; 8,692,008; 9,012,437; 9,018,210; 9,056,072; 9,061,044; 9,062,276; 9,210,924; 9,803,019; 9,878,017; 9,878,046 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in TriDiNetworks Ltd. v. Signify North America Corporation
Biologic Drugs cited in TriDiNetworks Ltd. v. Signify North America Corporation
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for TriDiNetworks Ltd. v. Signify North America Corporation (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-06-01 | 48 | Report and Recommendations | of the '276 patent against Signify US. (FAC at ¶¶ 32-39; see also D.I. 30 at 10) In the FAC, Plaintiff…infringement of the patent-in-suit. (D.I. 33 at 11-12 & exs. A-B) 5 Then, 4 …assignee of the patent- in-suit, United States Patent No. 8,437,276 (the “'276 patent”). (Id. at ¶ …924, 925 n.1 (3d Cir. 2006); Henderson v. Carlson, 812 F.2d 874, 878-79 (3d Cir. 1987). The parties…because the patented method had benefits over the prior art that were described in the patents’ specification | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |